Electroacupuncture treatments for gut motility disorders

Area of Science:

• Gastroenterology
• Complementary and Alternative Medicine
• Neurogastroenterology

Background:

• Functional gastrointestinal (GI) diseases are prevalent, with many patients exhibiting resistance to standard medical therapies.
• A significant number of patients with functional GI disorders turn to complementary and alternative medicine (CAM), including acupuncture and electroacupuncture (EA).
• Existing literature on EA for functional GI diseases presents some controversial findings, necessitating rigorous clinical investigation.

Purpose of the Study:

• To review clinical studies on the efficacy of electroacupuncture (EA) for various functional gastrointestinal diseases.
• To discuss critical aspects of EA clinical research, including stimulation parameters, administration frequency, and placebo selection.
• To explore the mechanisms of action underlying EA's therapeutic effects on gut dysmotility and suggest future research directions.

Main Methods:

• Review of multi-center clinical studies and trials investigating EA for functional dyspepsia and chronic functional constipation.
• Examination of research exploring EA's mechanisms via the enteric nervous system and neurotransmitters in animal models.
• Analysis of clinical studies on EA for gastro-esophageal reflux, functional dyspepsia, irritable bowel syndrome, and constipation.

Main Results:

• Recent multi-center, placebo-controlled studies suggest EA is effective for refractory functional dyspepsia and chronic functional constipation.
• Research indicates EA influences the enteric nervous system and neurotransmitters, contributing to its therapeutic effects on constipation in rats.
• The reviewed studies, despite some literature controversies, support the efficacy of EA when employing appropriate methodologies.

Conclusions:

• Electroacupuncture (EA), when applied with appropriate methodologies, is considered effective for managing certain functional gastrointestinal diseases.
• Optimizing EA stimulation parameters, administration frequency, and placebo controls are crucial for robust clinical research.
• Further investigation into EA's mechanisms of action for gut dysmotility is warranted to guide future therapeutic strategies.